Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
基本信息
- 批准号:10224611
- 负责人:
- 金额:$ 32.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary and Relevance
Many men diagnosed with prostate cancer will not die of it even without any intervention,
enhancing the possibility of overtreatment. How urologists organize themselves is strongly
linked to the nature and extent of treatment for localized prostate cancer. Those practicing in
large urology groups, particularly urologists with an ownership stake in radiation facilities, more
commonly treat men with prostate cancer who are unlikely to benefit (i.e., overtreatment).
Conversely, urologists in multispecialty groups provide care at a lower cost, without
compromising quality.
Uncertainty surrounding the implications of evolving health policy is prompting a sea change in
how physicians align themselves. Faced with increasing administrative burden to navigate
reforms, urologists practicing alone or in small groups are aligning themselves with larger
entities, including multispecialty groups and large urology groups. Because practice context is
strongly tied to prostate cancer overtreatment and spending, policy induced realignment of
urologists has significant public health implications. The goal of this national study is to
understand the effects of policy on relationships between urologist practice organization and
prostate cancer care (i.e., treatment, quality and payment). This grant, which uses national
Medicare data, has the following three aims: 1) To determine the effect of changing practice
organization on prostate cancer care; 2) To measure the effect of hospital ownership of urology
practices on prostate cancer care; and, 3) To determine how policy impacts relationships
between urologist practice organization and prostate cancer care. We plan to use interrupted
time series and difference-in-difference methods to control for differences in baseline case-mix
and temporal trends.
Results from this study have real-world implications for patients, who are naturally interested in
getting the best prostate cancer care at the lowest possible cost. Our findings will immediately
inform policymakers on the extent to which the impact of policy is mediated by practice
organization, particularly by those that have historically favored volume over value.
项目摘要和相关性
许多被诊断患有前列腺癌的男性即使没有任何干预也不会死于前列腺癌,
增加了过度治疗的可能性。泌尿科医生如何组织自己是强有力的
与局限性前列腺癌的治疗性质和程度有关。那些正在练习的人
大型泌尿外科集团,特别是拥有放射设施所有权的泌尿科医生,更多
通常治疗那些不太可能受益的前列腺癌男性(即过度治疗)。
相反,多专科组的泌尿科医生以较低的成本提供护理,而不需要
质量有问题。
围绕不断演变的卫生政策影响的不确定性正在促使
医生如何调整自己。面临越来越大的导航管理负担
改革,单独或以小组形式执业的泌尿科医生正在与更大的群体结盟
实体,包括多专科小组和大型泌尿外科小组。因为练习的背景是
与前列腺癌过度治疗和支出密切相关,政策促使重新调整
泌尿科医生对公共卫生有重大影响。这项全国性研究的目标是
了解政策对泌尿科医生执业组织和
前列腺癌护理(即治疗、质量和付款)。这笔赠款使用了National
医疗保险数据,有以下三个目标:1)确定改变做法的效果
前列腺癌护理组织;2)测量医院所有权对泌尿外科的影响
前列腺癌护理实践;以及,3)确定政策如何影响关系
在泌尿科医生执业组织和前列腺癌护理之间。我们计划使用中断的
控制基线病例组合差异的时间序列和差异法
和时间趋势。
这项研究的结果对患者具有现实意义,他们自然对
以尽可能低的成本获得最好的前列腺癌治疗。我们的调查结果将立即
告知政策制定者政策的影响在多大程度上受到实践的影响
组织,尤其是那些历来看重数量而不是价值的组织。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Value-based payment models and management of newly diagnosed prostate cancer.
- DOI:10.1002/cam4.6810
- 发表时间:2024-01
- 期刊:
- 影响因子:4
- 作者:
- 通讯作者:
In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer.
- DOI:10.1093/jncics/pkad062
- 发表时间:2023-07-03
- 期刊:
- 影响因子:4.4
- 作者:
- 通讯作者:
Hospital-physician integration and risk-coding intensity.
医院与医生的整合和风险编码强度。
- DOI:10.1002/hec.4516
- 发表时间:2022
- 期刊:
- 影响因子:2.1
- 作者:Post,Brady;Norton,EdwardC;Hollenbeck,BrentK;Ryan,AndrewM
- 通讯作者:Ryan,AndrewM
Hospital-physician integration and clinical volume in traditional Medicare.
- DOI:10.1111/1475-6773.14172
- 发表时间:2024-02
- 期刊:
- 影响因子:3.4
- 作者:Post, Brady;Hollenbeck, Brent K.;Norton, Edward C.;Ryan, Andrew M.
- 通讯作者:Ryan, Andrew M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRENT K. HOLLENBECK其他文献
BRENT K. HOLLENBECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRENT K. HOLLENBECK', 18)}}的其他基金
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
- 批准号:
10862259 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
- 批准号:
10560826 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10416477 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10592422 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10432116 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10625489 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10862329 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
- 批准号:
9750134 - 财政年份:2017
- 资助金额:
$ 32.8万 - 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
- 批准号:
9067196 - 财政年份:2015
- 资助金额:
$ 32.8万 - 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
- 批准号:
8874423 - 财政年份:2015
- 资助金额:
$ 32.8万 - 项目类别:
相似海外基金
Improving Patient-Centered Decision-Making for Stress Urinary Incontinence Treatment in Older Men
改善老年男性压力性尿失禁治疗中以患者为中心的决策
- 批准号:
10729838 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Optimizing Treatment Decision Making for Patients with Localized Renal Mass
优化局部肾脏肿块患者的治疗决策
- 批准号:
10734606 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10416477 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Singlet Oxygen-cleavable Prodrugs for Treating Non-Muscle Invasive Bladder Cancers
用于治疗非肌肉侵袭性膀胱癌的单线态氧可裂解前药
- 批准号:
10665068 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10592422 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer
优化膀胱癌患者的戒烟治疗
- 批准号:
10371383 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Improving urinary and sexual dysfunction after prostate surgery using shared decision making
使用共同决策改善前列腺手术后的泌尿和性功能障碍
- 批准号:
10064767 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
Optimizing Remote Access to Urinary Incontinence Treatment for Women Veterans
优化女性退伍军人的远程尿失禁治疗
- 批准号:
10651594 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
A Practice-based Intervention to Improve Care for Women with Urinary Incontinence
以实践为基础的干预措施,以改善对尿失禁女性的护理
- 批准号:
10257342 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
Optimizing Remote Access to Urinary Incontinence Treatment for Women Veterans
优化女性退伍军人的远程尿失禁治疗
- 批准号:
10754895 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别: